Technology | July 24, 2014

Boston Scientific Launches Polaris Combined IVUS/FFR Imaging System

Imaging system to support planned intravascular ultrasound and fractional flow reserve products

July 24, 2014 — Boston Scientific has initiated full commercial launch of its new Polaris imaging system. This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral and intracardiac echo products. The Polaris system offers enhanced ease-of-use and more powerful processing capabilities. Its modular design also will support the planned release of new Boston Scientific imaging products including a fractional flow reserve (FFR) wire, a new family of IVUS catheters, enhanced software features and better system control tools.

Working in collaboration with physicians, nurses, technicians and software design experts, Boston Scientific identified a need to improve the experience for customers involved in intravascular imaging procedures. Common challenges included confusing workflows, increased procedure times and difficult image interpretation. The Polaris system is designed to be smart, fast and accurate. The user interface and workflow have been redesigned and enhanced to provide for greater ease of use, while providing the necessary information to guide clinical decisions.

The Polaris system has CE mark and U.S. Food and Drug Administration (FDA) 510(k) clearance. It has been evaluated in numerous hospitals in the United States and Europe, and was showcased during live cases at the EuroPCR conference in May.

"The Polaris system is an advance for intravascular imaging," said Lowell Satler, M.D., director of coronary interventions, MedStar Washington Hospital Center, Washington, D.C. "The improved ease-of-use and image processing simplifies the procedure and enables our team to quickly obtain the information needed to treat patients."

Boston Scientific will offer customers an opportunity to upgrade their existing iLab system to the new Polaris.

"There are overwhelming data demonstrating that using IVUS improves patient outcomes," said Isaac Zacharias, vice president and general manager, imaging, Boston Scientific. "The Polaris system represents the ongoing commitment of Boston Scientific to develop products that improve patient outcomes by providing physicians improved IVUS guidance in their daily practice."

For more information: www.bostonscientific.com

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init